Become a member

Quick Registration

Full Registration Benefits -

Free Homepages for Doctors

Free Homepages for Hospitals

Free Homepages for Medical Conference

Free Homepages for NGO's

Personal Health Record Creation

Access to all Medical Slides

Access to all Jobs & Products Sale

Explore Medindia

Medindia » Drugs » FDA Approved Drugs

FDA Approved Drugs in 2010

Comprehensive list of FDA approved drugs by year. Drug information includes the drug name and indication of use.

Browse the FDA Approved Drugs by year

2013 2012 2011 2010 2009 2008

January	February	March	April
May	June	July	August
September	October	November	December

January

Tocilizumab Injection FDA Approves Actemra (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis	Emtricitabine- Rilpivirine- Tenofovir HIV/AIDS Update - Atripla (efavirenz, emtricitabine and tenofovir disoproxil fumarate) label update reflects new efficacy, safety and resistance data in treatment experienced patients
Dalfampridine FDA Approves Ampyra (dalfampridine)to Improve Walking in Adults with Multiple Sclerosis	Liraglutide [rDNA] Injection FDA Approves Novo-Nordisk's Diabetes Drug Victoza (liraglutide)
Darunavir U.S. Food and Drug Administration Approves Labeling Update for Prezista (darunavir) To Include 96-Week Data in HIV-1 Infected Adult Patients	Lapatinib GSK's Tykerb (lapatinib ditosylate) Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer

February

Trazodone Labopharm Receives FDA Approval for Oleptro (trazodone)	Collagenase Clostridium Histolyticum Auxilium Announces U.S. Food and Drug Administration Approval for Xiaflex (collagenase clostridium histolyticum) for the Treatment of Dupuytren's Contracture
Lamotrigine FDA Approves Once-A-Day Lamictal XR (lamotrigine) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures	Rosuvastatin FDA Approves Crestor (rosuvastatin calcium) to Reduce Stroke, Heart Attack Risk
Olmesartan FDA Approves Benicar (olmesartan medoxomil) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16	Ritonavir Abbott Receives U.S. FDA Approval for Heat-Stable Norvir (ritonavir) Tablets
Rituximab FDA Approves Rituxan (rituximab) to Treat Chronic Lymphocytic Leukemia	Meningococcal Conjugate Vaccine Novartis Gets US Approval for Menveo (meningococcal conjugate vaccine) Meningitis Vaccine
Aztreonam U.S. Food and Drug Administration Approves Cayston (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa	Pneumococcal Vaccine Polyvalent FDA Approves Prevnar 13 (pneumococcal 13-valent conjugate vaccine) Pneumococcal Disease Vaccine
Velaglucerase Alfa for Injection FDA Approves VPRIV (velaglucerase alfa) to Treat Gaucher Disease	Pneumococcal Vaccine Polyvalent FDA Expands Use of Prevnar 13 (pneumococcal 13-valent conjugate vaccine)Vaccine for People Ages 50 and Older

March

Hydromorphone FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets	Somatropin Novo Nordisk Receives FDA Approval for Norditropin FlexPro for Growth Hormone Treatment
Immune Globulin Subcutaneous CSL Behring Receives FDA Approval of Hizentra, First 20 Percent Subcutaneous Immunoglobulin Therapy	Onabotulinumtoxina Botox (onabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults
Decitabine FDA Approves Five-Day Dosing Regimen for Dacogen (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)	Triptorelin Pamoate for Injectable Suspension FDA Approves Watson's Trelstar 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
Doxepin Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia	Carglumic Acid FDA Approves Carbaglu to Treat Condition That Causes Elevated Ammonia Levels
Adapalene Galderma Received FDA Approval of Differin (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation	Pramipexole Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Rifaximin FDA Approves New Use of Xifaxan for Patients with Liver Disease	Imiquimod FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
Polidocanol Injection FDA Approves Asclera to Treat Small Varicose Veins	Imiquimod FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Imiquimod FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses

April

Oxycodone Hydrochloride FDA Approves New Formulation for OxyContin (oxycodone)	Pancrelipase FDA Approves Pancreatic Enzyme Product, Pancreaze (pancrelipase)
Miconazole FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis	Erlotinib FDA Approves Tarceva (erlotinib) as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
Immune globulin intravenous CSL Behring Receives FDA Approval to Extend Shelf Life for Privigen (immune globulin intravenous (human)) from 24 to 36 Months	Everolimus Novartis Receives US FDA Approval for Zortress (everolimus) to Prevent Organ Rejection in Adult Kidney Transplant Recipients
Lopinavir And Ritonavir Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (lopinavir / ritonavir) for Treatment-Experienced Patients	Sipuleucel-T Suspension FDA Approves Provenge (sipuleucel-T) - a Cellular Immunotherapy for Men With Advanced Prostate Cancer
Naproxen And Esomeprazole Magnesium FDA Approved Vimovo for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers

May

Pancrelipase Abbott Receives FDA Approval for Creon (pancrelipase) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy	Dienogest And Estradiol Valerate FDA Approves Natazia (dienogest and estradiol valerate) - New Combination Product Oral Contraceptive
Gatifloxacin Allergan Receives FDA Approval for Zymaxid (gatifloxacin) Ophthalmic Solution	Alglucosidase FDA Approves Lumizyme (alglucosidase alfa) for Late-Onset Pompe Disease
Hexaminolevulinate Hydrochloride Cysview (Hexaminolevulinate HCl) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer

June

Dutasteride And Tamsulosin FDA approves Jalyn (dutasteride and tamsulosin) , a fixed-dose combination of dutasteride and tamsulosin, for symptomatic BPH in men with an enlarged prostate	Cabazitaxel Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review
Nilotinib Novartis International AG (CH) - FDA approves Tasigna (nilotinib) for newly diagnosed chronic myeloid leukemia patients, data demonstrate major advance over Glivec	Vardenafil FDA approves Staxyn (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED)
Memantine Forest and Merz Announce FDA Approval of Namenda (memantine hydrochloride) XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type	Ranibizumab FDA Approves Lucentis (Ranibizumab Injection) for the Treatment of Macular Edema Following Retinal Vein Occlusion
Mometasone Furoate And Formoterol Fumarate FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older	Buprenorphine Purdue Pharma L.P. Receives FDA Approval for Butrans (buprenorphine) Transdermal System CIII
Sumatriptan FDA Approves Alsuma (sumatriptan) Auto-Injector	Denosumab FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Denosumab FDA Approves Amgen's Prolia (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture

July

Ondansetron FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film	Interferon Alfacon-1 Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of Infergen (interferon alfacon-1)
Alpha One-proteinase inhibitor Kamada Wins FDA Approval for Glassia (alpha1-proteinase inhibitor (human)) - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency	Methylphenidate FDA Approves Daytrana (methylphenidate transdermal system) CII for the Treatment of ADHD in Adolescents
Clindamycin And Tretinoin Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%	Donepezil Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Amlodipine , Hydrochlorothiazide and Olmesartan FDA Approves Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) , A New Three-In-One Combination Product for the Treatment of High Blood Pressure	Alcaftadine Ophthalmic Solution FDA Approves Lastacaft (alcaftadine ophthalmic solution) for Prevention of Itching Associated with Allergic Conjunctivitis
Glycopyrolate FDA Approves Cuvposa (glycopyrrolate) for Chronic Drooling in Children	Niacin Er And Simvastatin Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths

August

Valganciclovir FDA Approves Longer Use of Valcyte (valganciclovir) for Adult Kidney Transplant Patients at High Risk of Developing Cytomegalovirus (CMV) Disease	Ulipristal Acetate FDA Approves ella (ulipristal acetate) Tablets for Prescription Emergency Contraception
Aliskiren And Amlodipine Novartis receives FDA approval of Tekamlo (aliskiren and amlodipine), a single-pill combination of aliskiren and amlodipine to treat high blood pressure	Buprenorphine And Naloxone Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III
Docetaxel FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation	Sodium- Potassium- Magnesium Sulfate FDA Approves Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) Bowel Prep Kit

September

Fulvestrant FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women	Pralidoxime FDA Approves Pediatric Use of Protopam Chloride (pralidoxime chloride) Chemical Poisoning Treatment
Pegloticase FDA Approves Krystexxa (pegloticase) for Gout	Asenapine Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
Fingolimod Novartis Gains FDA Approval For Gilenya (fingolimod), A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression	Dexamethasone Ophthalmic Allergan Receives FDA Approval for Ozurdex (dexamethasone) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Clonidine Shionogi Announces FDA Approval of Kapvay (clonidine hydrochloride) - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD	Bimatoprost Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

October

Mannitol United States Food and Drug Administration Approves Aridol (mannitol)	Risedronate Warner Chilcott Announces FDA Approval of Atelvia (risedronate sodium) Next Generation Actonel
Calcipotriene Stiefel, a GSK company, Receives FDA Approval of Sorilux (calcipotriene) Foam, 0.005%	Naltrexone FDA Approves Vivitrol (naltrexone) to Treat Opioid-dependent Patients
Immune Globulin Intravenous And Subcutaneous Talecris Biotherapeutics Receives FDA Approval for Gamunex-C (immune globulin intravenous and subcutaneous)	Corticotropin FDA Approves H.P. Acthar Gel (corticotropin) for the Treatment of Infantile Spasms
Entecavir U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease	Dabigatran FDA Approves Pradaxa (dabigatran etexilate) to Prevent Stroke in People With Atrial Fibrillation
Bromfenac Ophthalmic Solution ISTA Pharmaceuticals Receives FDA Approval for Bromday (bromfenac)	Norethindrone- Ethinyl Estradiol- Ferrous Fumarate Warner Chilcott Announces FDA Approval of New Oral Contraceptive Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate)
Dasatinib FDA approves additional medical indication for Sprycel (dasatinib)	Lurasidone FDA approves Latuda (lurasidone) to treat schizophrenia in adults
Dextromethorphan And Quinidine Avanir Pharmaceuticals Announces FDA Approval of Nuedexta (dextromethorphan and quinidine)	Ceftaroline Fosamil Injection FDA Approves Teflaro (ceftaroline fosamil) for Bacterial Infections
Everolimus FDA Approves New Indication for Afinitor (everolimus)

November

Acetaminophen Cadence Pharmaceuticals Announces FDA Approval of Ofirmev (acetaminophen) injection for the Management of Pain and Fever	Duloxetine FDA Clears Cymbalta (duloxetine) to Treat Chronic Musculoskeletal Pain
Saxagliptin And Metformin Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults	Tesamorelin FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
Lisdexamfetamine FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents	Eribulin Mesylate FDA Approves Halaven (eribulin mesylate) for Late-Stage Breast Cancer
Denosumab FDA Approves Amgen's Xgeva (denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors	Amiodarone Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection
Moxifloxacin FDA Approves Moxeza (moxifloxacin) for Bacterial Conjunctivitis	Baclofen FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity
Testosterone Lilly and Acrux Receive FDA Approval for Axiron (Testosterone) Topical Solution CIII

December

Daptomycin Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of Cubicin (daptomycin )	Darunavir FDA Approves Prezista (darunavir) Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
Aliskiren, Amlodipine And Hydrochlorothiazide Novartis Gains FDA Approval for Amturnide (aliskiren, amlodipine and hydrochlorothiazide), a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications	Testosterone Endo Pharmaceuticals Receives FDA Approval for Fortesta (Testosterone) Gel as a Class III Product for Topical Use for Men With Low Testosterone

Browse the FDA Approved Drugs by year

2013 2012 2011 2010 2009 2008

January	February	March	April
May	June	July	August
September	October	November	December

Drug Manufacturers

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Manufacturers

Pharma Links

Recently added Drugs

Become a member

Health Encyclopedia A-Z

Health Topics A-Z

Health News A-Z

Health Calculators A-Z

Drugs A-Z

Health Animations A-Z

Baby Names A-Z

Search Doctors by City/State A-Z

FDA Approved Drugs in 2010

Comprehensive list of FDA approved drugs by year. Drug information includes the drug name and indication of use.

Browse the FDA Approved Drugs by year

Browse the FDA Approved Drugs by year

Consumers

Medical Professionals

Medical Students

Directories